Get startedLog in
    Picture of SciClone Pharmaceuticals (Holdings) logo

    6600 — SciClone Pharmaceuticals (Holdings) Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for SciClone Pharmaceuticals (Holdings), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:PROSPECTUSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line6618171,0269401,217
    Depreciation
    Amortisation
    Non-Cash Items20.5104127444194
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital314-53.5-231-319-153
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities1,0329811,0291,1841,404
    Capital Expenditures-32.6-469-191-196-77.6
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-120-20164.6-829587
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-152-671-126-1,026509
    Financing Cash Flow Items-212-2,183-3.180-5.84
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-235-53.3116-670-1,784
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash6441991,009-456137